The price of Enbrel (etanercept) varies significantly based on factors such as dosage, insurance coverage, and geographic location. Without insurance, a one-month supply of Enbrel can cost upwards of $6,000 in the United States [1].
How much does Enbrel cost with insurance?
Insurance plans can substantially reduce out-of-pocket costs for Enbrel. Many plans offer copay programs or patient assistance programs that can bring the monthly cost down to anywhere from $0 to $200. However, deductibles, coinsurance, and formulary restrictions can still impact the final price [1].
What assistance programs are available for Enbrel?
For eligible patients in the U.S., Amgen, the manufacturer of Enbrel, offers the Enbrel Support (Enbrel4Me) program. This program can provide as-needed free medication for eligible uninsured or underinsured patients who meet specific income requirements [1]. Additionally, some insurance plans have their own copay assistance programs.
When does Enbrel's patent expire?
Enbrel, a biologic drug, has complex patent protection that differs from small-molecule drugs. While initial patents have expired, Amgen has pursued additional patent litigation to protect its market. For instance, patent challenges have occurred in recent years regarding its market exclusivity. Information on specific patent expiry dates and ongoing litigation can be found through resources like DrugPatentWatch.com [2].
Who are Enbrel's main competitors?
Enbrel is a tumor necrosis factor (TNF) inhibitor used to treat autoimmune conditions like rheumatoid arthritis, psoriatic arthritis, and plaque psoriasis. Other major TNF inhibitors in the market include Humira (adalimumab), Remicade (infliximab), and Simponi (golimumab) [3]. The introduction of biosimilars for some of these medications has also introduced competitive pressures.